{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:48:59Z","timestamp":1791215339477,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ijantimicag.2005.08.005","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T11:13:45Z","timestamp":1129893225000},"page":"408-411","source":"Crossref","is-referenced-by-count":30,"title":["Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children"],"prefix":"10.1016","volume":"26","author":[{"given":"Paul N.","family":"Goldwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.08.005_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199105303242201","article-title":"The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis","volume":"324","author":"Odio","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1128\/AEM.19.4.573-579.1970","article-title":"Microassay of antimicrobial agents","volume":"19","author":"Simon","year":"1970","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib3","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A4. Villanova, PA: NCCLS; 1990."},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib4","series-title":"Manual of clinical microbiology","first-page":"972","article-title":"Susceptibility tests: microdilution and macrodilution broth procedures","author":"Jones","year":"1985"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1017\/S0022172400060782","article-title":"Pneumococcal carriage amongst Australian Aborigines in Alice Springs, Northern Territory","volume":"95","author":"Hansman","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000007106","article-title":"Prospective comparison of ceftriaxone and cefotaxime for short-term treatment of bacterial meningitis in children","volume":"44","author":"Scholz","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.143.9.1705","article-title":"Cefotaxime therapy: evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity","volume":"143","author":"Mullaney","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/143.2.156","article-title":"Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone and Rocephin in experimental bacterial meningitis","volume":"143","author":"Schaad","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib9","first-page":"813","article-title":"Study on the penetration of ceftriaxone into cerebrospinal fluid","volume":"49","author":"Hattori","year":"1996","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2005.08.005_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/AAC.38.5.1209","article-title":"Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone","volume":"38","author":"Gaillard","year":"1994","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T12:30:58Z","timestamp":1586521858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790500230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S092485790500230X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.08.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}